This can be especially important for those in or nearing menopause , when loss of bone mass often occurs
e70113, Sep
In the following sections, we'll explore these insights and their implications for the CPG industry, providing a roadmap for companies to navigate this new landscape successfully
A new study published in The BMJ has found that adults with type 2 diabetes who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including medications such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), may face a higher risk of developing non-scarring hair loss (alopecia) compared with patients taking other commonly prescribed diabetes medicines
At Balanced Bodies: Longevity + Wellness Clinic, we offer personalized infusions to deliver the hydration, nutrients, and vitamins your body needs directly into your bloodstream for quicker results
Most trials reported either no or minimal GSH adverse effects, but all had treatment durations of a few doses (IV) or 4 - 12 weeks